Delivery Order SPE2DB24D1021-SPE2DB25FFAFZ
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $48K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 22, 2025, for Deferiprone 500 mg tablets (100-count packages) valued at $6,470.85. This competitively awarded, firm fixed-price contract is funded by the Medical Supply Chain, a defense-focused federal procurement entity, with an ultimate completion date of July 23, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 360 MG TABLET 30S, a medical product, with a ceiling value of $54,663.84 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 100 tablets of the prescription drug deferiprone 500 mg. The contract has a ceiling value of $6,382 and an ultimate completion date of September 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, serving as a primary supplier of pharmaceutical and medical products to support...
- AmerSourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Deferasirox 500 mg tablets for suspension in quantities of 30 units. This is a firm fixed-price contract with a ceiling value of $12,359.49 and an ultimate completion date of September 4, 2025. The contract represents a competitively awarded, non-set-aside procurement with performance to be executed at the vendor's Conshohocken, Pennsylvania location. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Deferasirox 500 mg Tablets for Suspension. The contract has a ceiling value of $5,629.92 and an ultimate completion date of September 13, 2024. This is a Firm Fixed Price contract for the delivery of this pharmaceutical product. The award is not associated with any set-aside designation. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,063.08, is for the delivery of Deferiprone 1,000 mg tablets to support military healthcare programs. The contract is a firm-fixed price type, with an ultimate completion date of January 18, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...